With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling high-risk, high-reward investment. Read more on ATYR stock here.

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

Among skin cancers, squamous cell carcinoma (SCC) accounts for the majority of metastatic cancers and deaths related to non-melanoma skin cancers (NMSC). This study is the first to use the Vision ...

Furthermore, the proportion of SCC and baseline NLR could affect the prognostic value ... age, median follow-up time, histology, NLR cut-off value, NLR at baseline, line of therapy, drugs and HRs with ...

In women with positive cervical histopathology, the hr-HPV infection rate reached ... high-grade squamous intraepithelial lesion (HSIL); and d, squamous cell carcinoma (SCC); (3) glandular epithelial ...

Scottsdale Community College (SCC) has launched its first-ever four-year degree program, a Bachelor of Business Administration in Management (BBA). Leadership isn’t just about ambition — it ...

Virginia: SCC faults Cigna's coverage of transgender, autism treatment Such reductions are prohibited, and telling customers incorrect information about that is a violation of state law ...

Clinical Impact and Genomic Features of Human Epidermal Growth Factor Receptor 2–Low Tumors in BRCA1/2-Mutated Triple-Negative Breast Cancer Of the 103 patients with CPS recommended for WB-MRI ...

Of 131 patients evaluated, 14 patients developed the spectrum of SCC/AK within 9.3 months of starting sorafenib (median, 6.5 months; range, 0.9–43 months). The median duration of follow-up for ...